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B,sOk0m~ Hen~t failure con now bo tmaled e f t ,  t~t it can be d~ff~. 
~no~ In ~al~ls_ ~ _~m,Fr~toma~ kffl ventm~lar (LV)impaJmlnt, 
~m,W~Y 
Me~q_~.b.- We. am ~men~ 7QO0 pa,ent= aged 4~ ~nd above tram Ihe 
O0m~unily in WeS! ~ ~ 011Ert0~nd: 4000 randondy imlecled aged 
4~; 1000 v~ a ~  dU~,ne, m ~ ~ ;  100~ o~¢we~-=; 
an~ I000 ~ "mk facies' ~o~ head farm ~ m. ~ .  ~mene,. 
==o~ O~ angi~). Pafiem asse=m~em ¢lud~ ¢1in¢~ hist. /and exammatmn, 
ECG, and ed~ocanfm~,  uath co~o~r Ito~ and =iPecbal ~ ~l ies .  
~ -  Tbe ~ ¢lotads Hhe I tn~ m the 5rst 2B5~ ~ .  EF= 
~ oc va~e,~ceme~ 
45~pOlp~a~=a~e 40~z254 it 8%) 40~2254(1~%) 7(Y2254t31%) 
I~dkO~dhead l l t la~we 52tt75(L~93~,) 18/175t103%l 5~,'175(32(T%1 
(~t CbJ~4u¢~ L~ (11 8%) lO,~o~ (4 9'%) ~ (16.3%) 
H~gt~m~ gmUp~ 25~06 tB.2%) 15~JO6 t4 g~=~ 22,"306(72%) 
~ :  The We~,-,,:6 of de~n,~ LV sySte~ ~xsfur¢tk~ was I.:;:o 
m the popula~on sample. Ordy 30% of Itmse vd~ose GP had diagnosed heart 
ta~hu~ bed der~m systo~ dysfu~on. Vah,e o~sease was fraque,,~y found 
m ease with a dragnets of heart ~ ,  often as the onty al~normardy 
~ l~tral  Valve Prolapse Recon=Iden~: 
and EpiOemiology in the Fromingham Heart Study 
L_A. Freed. D. Le.ty. R.A. Levme. MG. ~ J.C. Evans. D.L FuJler, 
e_ Lehma~ AJ. 3enlamin. ~assachuseKs Get(eta/Hos~ta/. Boston. A,~L- 
NHLBt3 F t -~ham Heart Stuo~, Fmnvnghan~ MA. USA 
Esttn~tes at th,= prevatence of =~bal valve pm~3se (MVP) generelly, have 
been de~=d ~nt  hosl~.al-based referral popu~K~ns and am as ~ as 7% 
of men and 21% at women. To detew,~ne Ihe ima~alenco at MVP in lt~e germ.we! 
populatio~ d ia~ (:sing cunrent 2D e ~  criteria, we eves- 
ined the ed loca ld t~ of 3487 sub~l~'ls ( 1842 women, 1645 men) in Ihe 
Framingl~m Offspring Study. Mistreat mibal leaflet superior d~splacement in 
systole (D) and leaflet ffdctmess in dtaslasis ('f) were measured. "the sut01ects 
were classified as classic MVP (D >2mm, T ~ Smm), nonclass¢ MVP(D >2 
ms, T < 5 ms), or no MVP (D ~ 2 ms). 
/ ; ~  at Total |%) ~ i%) I~n I%) 
C/ass¢ MVP 46 (13%) 25 (1.4%) 21 (13%) 
~ M V P  37(1.1%) 24(1 3%) 13 (0 8%) 
Compared with the general sample, MVP subjects had s~rmlar age and 
gender distnbutmn and prevalence of hypert~nsio~=, but were significantly 
leaner (,2.6 kgh~ , p = 0.0001). There were no MVP subjects with heart fail- 
ure. one with atrial fibrillation, and one with stroke, compared with population 
prevalences of 0.6. 1.6. and 1 5% 
Conclusions: 1. The prevalenCe of MVP in this healthy unsalected popula- 
tion is fewer than previously reported. 2. Adverse sequelae commonly associ- 
ated with MVP in referral populations are ram in our MVP cases identified in a 
genera( imputation, 
~ A  National Screening Program for the 
Identif ication of  Pemons With Familial 
Hypercholesterolemla in the Netherlands 
M.A.W. Umans-Eckenhausen ~ , J.C. Defesche ~, F. Clind ~, J.J.P. Kaslelein ~. 
The StOEH. the Netherlands: 2 The Academic Medical Center, Amsterdam, 
the Netherlands: 3The Ministry of Health, Rijswijk, the Netherlands 
Background: The Dutch Government encouraged the development of an ac- 
live somenmg program for ~nt i rcat~ of Famtl~ ~de i le~im.~ 
(FH) pts to ensure 0ariy d~gf~lls and tmstme~ to prevent Carff~Ovascuiar 
• sease, 1"~s program is executed mnce 1993 by the StOEH 
Meth(x~ A nat~rvw~te neh,,~o~ of I~,¢1 ¢1i~¢:~ was esla~,she¢l to ~uty  
FH index pit, Su~uen l ly  mtabvei were 1orNery ¢o~l¢te4 ~ =¢f~me~ 
ReW~Afs, 0etweml 1993 0rtcIJ~y 1907 1341 mdml pts midtmt~,  
famly ~LmmO Wa~ ~ in Ie9 latona, Pwlc~u~ rote o~ ~ 
~'~. Num~ at reeves ~mer4xl ~,e0. Num~ of R.I I~ mn~ed !20~ 
(37%). S~ (41%) maim and ~ (SS%I mmm. O! ,~  FH mW~: ~ (~'~) 
~x~t a ¢~k~,o l  tv, g~r then 390 m0~, 37 0~,) ~z0o~t ¢a~ovnzm~, ¢~ 
~ at ~ of ~ca lk~.  For the femal~ IP~e~ nomoem am ~p~cfivmy 
~S (4t %1 and 44 C/%), O~h/10% of R.Ipt= meowed adequm r , ,~w~t p~o~ 
to ~n0,  Aftra ~mtdtcatmn, 03% of pt~ meeiv~l ndequm t~otme~ 
~ sek~v~ a~ efft~m m the ident~=~ o~ ~w ~=et  The mu~t 
~ amqum e~pout¢  ~ ~ me p f~p~=~ p~we m r~ 
e~zease fo~ mo~t pts, ~ such n~ program ten ~ an ~ ~ to tt~ 
ez~mmO pmgrar~ for the prevemmn of c~rdtovascular (hsaxS, 
~ ~no ldn0  and HDL-C!tokmlwrol In a !XopgtaUo~ of 
C P~savols, I Sk~u~nas, V Koulo~d~s, M Toutouza, A Do~lalas, 
S. Paxima¢l~, N G~,  S. Vama, S. Lan~mu, C Slefana~s, 
P. Touts__ ~,~. _. ~ HON~, A~tm~ Unn~a~ G~wece 
aa~x~o~-The advenre m~-t m =me=~g m p,~awna HOL-¢he~ (HOL.Cl 
r~as f~m esu~shed by e l~Wno~ s tu ,~ mama, in .w(ae.,age¢ pe~. 
softs. In co~asl. Ibe mI.Mmn between smokJ~ aml HDL-C nt yotm9 heaJ1~ 
~u~s bes ~ot bee~ adequately mZ~dted, fa offer to fumw, r ~ mis 
msu~, we s~udied 1954 from a Imputabon of 2QO9 ma~e re~,utts of the Greek 
an~, aged 223 ± 2.9 yearn. 
MemOs: Fqasma ~ ~ (total ch0~e~e~, tnQ~,~:endes and HaL-C) 
wee measured and a medical I1islo~y was coml~eted m all recruits. We con- 
sxle~¢l as smoke those t,,~o .=~.'.=,:1 smok~ > 10 c:~amt~ per o~y (r..~) 
for ~t least ~ yea~, wh~e reo'ui~ smolang < 10 C/~ o~ lot < 1 year (n = 55) 
were e~h~ ~om ~e gudy. Mean bedy mass index (BI~) m ~ popumt~o. 
was 23.4 ± 3.3 kgr,~-. 
Resu/ts: Of ~ total populal~n, 759 reo~ (38.8%) were snto~m and 
1195 (61~%) wef~ nof~smokere. No siQ~ifiCa~ differeno~ wt~m found be- 
tweet( ~ ~ non-smokers regaKflng BMI (23.4 :~ 3,3 ve 23.3 ± 32 
kgr/m z, p = NS). a~e (22.2 ~: 3 vs 22.4 ± 2.9 yearn, p = NS) and plasma 
HDL-C (45.4 ~: 12 ~s 45.4 ± 0.6 r~cfl, p = NS). Multiple regres~o~ ar i -  
ses wa~ eml~ Io evah~ate I/le ~ between HDL-C and duratKm 
of smotur~, dady ~ consurnptmn, zdcohof consun'q3tzon, BMI and age. 
Only al~'~hoI cor~m~ was found tO affect HDL-C valUeS ~hJ  (a = 
0096. p = 0 003) in addffion. ~ retalm~ between HDL-C values (now de- 
r~e~ase~er >-3Sm~dlo~ >4Smg~d;) and~ea lomm~ed vanaU~ptu= 
,~,~,:.,~ was eva~ W togis~ regnmUon analy~. A ~ ome~r,o. 
was n~,~ealed be~,een alco~ o:..,-,~mp~n and HDL,C values ~35 mg/~ (B 
= 0.032. p =O.04) as weg as betwe~ HDL-C _>45 m9/ol and ak:otlol ¢onsum~- 
I~n. exerose ar¢l age (e = 0.024. p = 0.05; B = 0.15, p = 0.03 and B = 0.047. 
p = 0.00 mspectM~y). The pamal coe,T,~em o~ conem~n behveen smo~ 
and HOL-C (zero order} was 0.018 (p = NS); whe~ aloohol cormuml~on, BMI 
and age ~re  not in,stied ~n Ihe analys~ (3 ~ oKler), ~s value was -0.0085 
(p = NS). 
~ -  HDL-C is not infk~-~-~ by smoking in young Greek male 
adults. This fact may mdtcate that the adverse effect of smoking in plasma 
HDL-C LS expressed after a ~'~er penod of exposure to smoking, or that it is 
me.tied by ¢~etary facies (Medffenanean diet). 
~ Geographical Variation in Cardiovascular Risk 
Factors in Fa;',~v,t~ With Coronary Heart Oiselme 
in Nine European Countries (EUROASPIRE) 
D. Wood. On behalf of ~ EUROASPIRE invesl*tgators; Impenal College 
School of Medicine, London. UK 
In a nine COuntn/European survey o Czech Republic. Finland, France, Ger- 
many, Hungan/, Italy, Netherlands. SIovema and Spain - there was cons~er- 
able variatiOn in •e prevalence of cardiovascular risk factors in p~tients with 
corona W heart disease. Consecutive patients within 4 diagnsotic ategories 
(CABG, PTCA, acute myocardial ischaemra nd myocardial ischaemia with- 
out infarction) were identified in a sample of ~ within a geogral~'~cet 
area. 3569 patients were interviewed (edlusted response rate 85%) 6 months 
or later after the index event. At inten,,iew the prevalence of current smoking 
ranged from 12% in Spain to 32~'.- in the Netherlands. Overell men smoked 
(21%) more commonly than women (14%). Obesity (BMI >_30 kg/m2) ranged 
from 19% in the Netherlands tn 33% in France Raised blood pressure (SBP 
